Concepedia

Publication | Open Access

Nintedanib in progressive interstitial lung diseases: data from the whole INBUILD trial

DOIFull Paper Access

102

Citations

14

References

2021

Year

Kevin R. Flaherty, Athol U. Wells, Vincent Cottin, Anand Devaraj, Yoshikazu Inoue, Luca Richeldi, Simon Walsh, Martin Kolb, Dirk Koschel, Teng Moua,
European Respiratory Journal

Abstract

Based on data from the whole INBUILD trial, nintedanib reduced the risk of events indicating ILD progression.

References

YearCitations

Page 1